Advantage Investment Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Advantage Investment Management's PFE Position: Q3 2019 in Review
Advantage Investment Management reduced its Pfizer (PFE) stake by 5.1% in Q3 2019, selling an estimated $12.5K and leaving 6,409 shares worth $218K. The position accounts for 0.17% of the portfolio, ranked #137.
Advantage Investment Management first reported a position in PFE in Q4 2014 and has held it in 20 quarters since. The position peaked at $504K in Q2 2017. 2,322 funds tracked by Wall St. Rank hold PFE as of Q3 2019.
- Advantage Investment Management held 6,409 shares of Pfizer worth $218K as of Q3 2019.
- Advantage Investment Management sold 344 Pfizer shares in Q3 2019, an estimated $12.5K.
- Pfizer made up 0.17% of Advantage Investment Management's portfolio in Q3 2019, its #137 holding.
- Advantage Investment Management first reported a position in Pfizer in Q4 2014 and has held it in 20 quarters since.
- Advantage Investment Management's Pfizer position peaked at $504K in Q2 2017.
- 2,322 funds tracked by Wall St. Rank held Pfizer as of Q3 2019.
Based on Advantage Investment Management's 13F filing for Q3 2019, filed 8 Oct 2019.